Sandbox/WCT: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 28: Line 28:


{{Family tree/start}}
{{Family tree/start}}
{{familytree | | | | | | | A01 | | |A01=<div style="float: left; text-align: left; width: 18em; padding:1em;">'''Identify cardinal findings that increase the pretest probability of wide complex tachycardia''' <br>❑ [[Palpitations]] <br>❑ [[Heart rate]] > 100 beats/min <br>❑ [[QRS complex]] > 120 ms </div> <br> }}
{{familytree | | | | | | | | | | | | | A01 | | |A01=<div style="float: left; text-align: left; width: 15em; padding:1em;">'''Identify cardinal findings that increase the pretest probability of wide complex tachycardia''' <br>❑ [[Palpitations]] <br> ❑ [[QRS complex]] > 120 ms <br>❑ [[Heart rate]] > 150 beats/min </div> <br> }}
{{familytree | | | | | | | |!| | | }}
{{familytree | | | | | | | | | | | | | |!| | | }}
{{familytree | | | | | | | B01 | | |B01=<div style="float: left; text-align: left; width: 18em; padding:1em;">'''Does the patient have any of the following findings that require urgent cardioversion?''' <br>
{{familytree | | | | | | | | | | | | | B01 | | |B01=<div style="float: left; text-align: left; width: 13em; padding:1em;">'''Does the patient have any of the following findings that require urgent cardioversion?''' <br>
❑ Hemodynamic instability
❑ Hemodynamic instability
:❑ [[Hypotension]]
:❑ [[Hypotension]]
Line 39: Line 39:
❑ [[Chest discomfort]] suggestive of [[ischemia]] <br>
❑ [[Chest discomfort]] suggestive of [[ischemia]] <br>
❑ [[Heart failure|Decompensated heart failure]]</div>}}
❑ [[Heart failure|Decompensated heart failure]]</div>}}
{{familytree | | | |,|-|-|-|^|-|-|-|.| | | | | | | | | | | }}
{{familytree | | | | | | | | | |,|-|-|-|^|-|-|-|.| | | | | | | | | | | }}
{{familytree | | | B01 | | | | | | B02 | | | | | | | | | | |B01=<div style="float: left; text-align: left; background: #FA8072; width: 15em; padding:1em;"> {{fontcolor|#F8F8FF| ❑ '''Yes'''}} </div>|B02=❑ '''No'''}}
{{familytree | | | | | | | | | B01 | | | | | | B02 | | | | | | | | | | |B01=<div style="float: left; text-align: central; background: #FA8072; width: 13em; padding:1em;"> {{fontcolor|#F8F8FF| ❑ '''Yes'''}} </div>|B02=❑ '''No'''}}
{{familytree | | | |!| | | | | | | |!| | | | | | | | |}}
{{familytree | | | | | | | | | |!| | | | | | | |!| | | | | | | | |}}
{{familytree | | | C01 | | | | | | C02 | | | | C01=<div style="float: left; text-align: left; background: #FA8072; width: 15em; padding:1em;"> {{fontcolor|#F8F8FF| ❑ Urgent [[synchronized cardioversion|<span style="color:white;">synchronized cardioversion</span>]]<br>
{{familytree | | | | | | | | | |!| | | | | | | C02 | | | | |C02=<div style="float: left; text-align: left; width: 13em; padding:1em;">  ❑ '''[[Wide complex tachycardia resident survival guide#Complete Diagnostic Approach|Continue with the complete diagnostic approach below]]''' </div>}}
:Provide an initial shock of 100 Joules
{{familytree | | | | | | | | | C03 | | | | | | | | | | | | | | | |C03=<div style="float: left; text-align: left; background: #FA8072; width: 13em; padding:1em;"> {{fontcolor|#F8F8FF| '''Prepare the patient for immediate cardioversion and simultaneously do the following:'''<br>  ❑ Maintain patent airway; assist breathing as necessary<br> ❑ Adminster [[oxygen]] (if the patient is hypoxemic)<br> ❑ Cardiac monitor to identify rhythm; monitor [[blood pressure]] and oximetry <br> ❑ Give IV sedation if the patient is conscious (don't delay cardioversion to sedate the patient) <br> ❑ Consider expert consultation }} </div>}}
:❑ If there is no response to the first shock, increase the dose in a stepwise fashion (eg, 100 J, 200 J, 300 J, 360 J)<ref name="ACLS">{{Cite web  | last =  | first =  | title = Part 8: Adult Advanced Cardiovascular Life Support | url = http://circ.ahajournals.org/content/122/18_suppl_3/S729.full | publisher =  | date =  | accessdate = 3 April 2014 }}</ref><ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary | url = http://circ.ahajournals.org/content/108/15/1871 | publisher = | date =  | accessdate = 15 August 2013 }}</ref>
{{familytree | | | | |,|-|-|-|-|+|-|-|-|-|.| | | | | | | | | | | |}}
❑ If a patient has polymorphic VT and is unstable, treat the rhythm as VF and deliver high-energy unsynchronized shocks
{{familytree | | | | A01 | | | A02 | | | A03 | | | | | | | | | | |A01=<div style=" width: 13em; padding:1em;"> <div style="background: #FA8072"> {{fontcolor|#F8F8FF| '''[[VT]]/[[VF]] in the form of [[cardiac arrest]]'''<br> '''[[Cardiac arrest resident survival guide|<span style="color:white;">Click here for Cardiac arrest resident survival guide</span>]]''' }} </div> </div> |A02=<div style=" width: 13em; padding:1em;"> <div style="background: #FA8072"> {{fontcolor|#F8F8FF| '''Unsynchronized cardioversion'''<br> ❑ If a patient has polymorphic VT and is unstable, treat the rhythm as VF and deliver high-energy unsynchronized shocks <br>
:❑ Provide an initial shock of 200 Joules
:❑ Provide an initial shock of 200 Joules<br>
:❑ Increase the dose if no response to the first shock (eg, 300 J, 360 J, 360 J)<ref name="ACLS">{{Cite web  | last = | first = | title = Part 8: Adult Advanced Cardiovascular Life Support | url = http://circ.ahajournals.org/content/122/18_suppl_3/S729.full | publisher =  | date =  | accessdate = 3 April 2014 }}</ref><ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary | url = http://circ.ahajournals.org/content/108/15/1871 | publisher =  | date =  | accessdate = 15 August 2013 }}</ref>
:❑ Increase the dose if no response to the first shock (eg, 300 J, 360 J, 360 J) }} </div> </div>|A03=<div style=" width: 13em; padding:1em;"> <div style="background: #FA8072"> {{fontcolor|#F8F8FF| '''Synchronized cardioversion''' }} </div> </div>}}
❑ Give IV sedation if the patient is conscious
{{familytree | | | | | | | | | | | |,|-|-|+|-|-|.| | | | | | | | }}
❑ Consider expert consultation }}<ref name="ACLS">{{Cite web  | last =  | first =  | title = Part 8: Adult Advanced Cardiovascular Life Support | url = http://circ.ahajournals.org/content/122/18_suppl_3/S729.full | publisher =  | date =  | accessdate = 3 April 2014 }}</ref><ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary | url = http://circ.ahajournals.org/content/108/15/1871 | publisher =  | date =  | accessdate = 15 August 2013 }}</ref> </div> |C02=<div style="float: left; text-align: left; width: 15em; padding:1em;"> '''[[Narrow complex tachycardia resident survival guide#Complete Diagnostic Approach|Continue with the complete diagnostic approach below]]''' </div>}}
{{familytree | | | | | | | | | | D01 | | D02 | | D03 | | | | | | |D01=<div style="float: left; text-align: left; background: #FA8072; width: 13em; padding:1em;"> {{fontcolor|#F8F8FF| '''Atrial fibrillation with aberrancy'''
{{familytree | | | |!| | | | | }}
:❑ Provide an initial dose of biphasic cardioversion of 120-200 Joules ([[ACC AHA guidelines classification scheme|<span style="color:white;">Class IIa, level of evidence A</span>]])
{{familytree | | | D01 | | | | D01= <div style="float: left; text-align: left; width: 15em; padding:1em;">❑ '''[[Narrow complex tachycardia resident survival guide#Complete Diagnostic Approach|After the stabilization of the patient, continue with the complete diagnostic approach below]]''' </div>}}
:❑ If the initial shock fails, increase the dose in a stepwise fashion }} </div>|D02=<div style="float: left; text-align: left; background: #FA8072; width: 13em; padding:1em;"> {{fontcolor|#F8F8FF| '''Arial flutter and other SVTs with aberrancy'''
:❑ Provide an initial dose of biphasic cardioversion of 50-100 Joules ([[ACC AHA guidelines classification scheme|<span style="color:white;">Class IIa, level of evidence B</span>]])
:❑ If the initial shock fails, increase the dose in a stepwise fashion
:❑ If monophasic wave form is used, begin at 200 Joules and increase in stepwise fashion if not successful }} </div>|D03=<div style="float: left; text-align: left; background: #FA8072; width: 13em; padding:1em;"> {{fontcolor|#F8F8FF| '''Monomorphic VT (regular form and rate)'''
:❑ Provide an initial dose of biphasic cardioversion of 100 Joules ([[ACC AHA guidelines classification scheme|<span style="color:white;">Class IIb, level of evidence C</span>]])
:❑ If the initial shock fails, increase the dose in a stepwise fashion }} </div> }}
{{familytree | | | | | | | | | | |`|-|-|-|+|-|-|-|'| | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | D01 | | |D01= <div style="float: left; text-align: left; width: 13em; padding:1em;">❑ '''[[Wide complex tachycardia resident survival guide#Complete Diagnostic Approach|After the stabilization of the patient, continue with the complete diagnostic approach below]]''' </div>}}
{{Family tree/end}}
{{Family tree/end}}



Revision as of 17:39, 10 April 2014

Wide Complex Tachycardia Resident Survival Guide Microchapters
Overview
Causes
FIRE
Diagnosis
Treatment
Do's
Don'ts

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

For the mobile version, click here

Overview

Wide complex tachycardia is characterized by a heart rate more than 100 beats per minute associated with a QRS interval of more than 120 ms. When wide complex tachycardia is present, it is important to determine whether the tachycardia is of a supraventricular or a ventricular origin. The diagnosis of wide complex tachycardia is very challenging as there is no fixed criteria to accurately determine the cause and type of the WCT. Hemodynamically unstable patients should receive urgent synchronized cardioversion. If the QRS complex and the T wave can't be distinguished in unstable patients, then we proceed with unsynchronized cardioversion.[1]

Causes

Life Threatening Causes

Wide complex tachycardia may be a life-threatening condition and must be treated as such irrespective of the causes.

Common Causes

Click here for the complete list of causes.

FIRE: Focused Initial Rapid Evaluation

A Focused Initial Rapid Evaluation (FIRE) as shown below should be performed to identify patients in need of immediate intervention.[1][2]

Boxes in salmon signify that an urgent management is needed.

 
 
 
 
 
 
 
 
 
 
 
 
Identify cardinal findings that increase the pretest probability of wide complex tachycardia
Palpitations
QRS complex > 120 ms
Heart rate > 150 beats/min

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have any of the following findings that require urgent cardioversion?

❑ Hemodynamic instability

Hypotension
Cold extremities
Peripheral cyanosis
Mottling
Altered mental status

Chest discomfort suggestive of ischemia

Decompensated heart failure
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prepare the patient for immediate cardioversion and simultaneously do the following:
❑ Maintain patent airway; assist breathing as necessary
❑ Adminster oxygen (if the patient is hypoxemic)
❑ Cardiac monitor to identify rhythm; monitor blood pressure and oximetry
❑ Give IV sedation if the patient is conscious (don't delay cardioversion to sedate the patient)
❑ Consider expert consultation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unsynchronized cardioversion
❑ If a patient has polymorphic VT and is unstable, treat the rhythm as VF and deliver high-energy unsynchronized shocks
❑ Provide an initial shock of 200 Joules
❑ Increase the dose if no response to the first shock (eg, 300 J, 360 J, 360 J)
 
 
Synchronized cardioversion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Atrial fibrillation with aberrancy
❑ Provide an initial dose of biphasic cardioversion of 120-200 Joules (Class IIa, level of evidence A)
❑ If the initial shock fails, increase the dose in a stepwise fashion
 
Arial flutter and other SVTs with aberrancy
❑ Provide an initial dose of biphasic cardioversion of 50-100 Joules (Class IIa, level of evidence B)
❑ If the initial shock fails, increase the dose in a stepwise fashion
❑ If monophasic wave form is used, begin at 200 Joules and increase in stepwise fashion if not successful
 
Monomorphic VT (regular form and rate)
❑ Provide an initial dose of biphasic cardioversion of 100 Joules (Class IIb, level of evidence C)
❑ If the initial shock fails, increase the dose in a stepwise fashion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Complete Diagnostic Approach

A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.[1][2]

Click on boxes to expand/collapse detailed information.


Characterize the symptoms

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Characterize the timing of the symptoms

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Identify possible triggers

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

❑ Examine the patient
❑ Order an EKG

 
 
 
 
 
 
 
 
 
 

Characterize the symptoms

❑ Asymptomatic
Palpitations
Dyspnea
Fatigue
Chest discomfort
Lightheadedness
Syncope

Characterize the timing of the symptoms

❑ Onset
❑ Duration
❑ Frequency

Treatment

A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.[1][2]

ABC: Air, breathing and circulation; Afib: Atrial fibrillation; BBB: Bundle branch block; LV: Left ventricle; SVT: Supraventricular tachycardia; VT: Ventricular tachycardia; WPW: Wold Parkinson White

Click on boxes to expand/collapse detailed information.


 
 
 
 
 
 
 
 
 
 

Wide complex tachycardia
QRS ≥ 120ms

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Begin initial management

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Determine if the patient has any unstable sign or symptom

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

No

 
 
 
 
 
 
 

Yes

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Determine the regularity of the rhythm

 
 
 
 
 
 
 

Perform immediate synchronized cardioversion

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Regular rhythm

 
 
 
 
 
 
 

Irregular rhythm

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

VT or uncertain rhythm

 

SVT with aberrancy

 

Afib with aberrancy

 

Pre-excited Afib (Afib + WPW)

 

Recurrent polymorphic VT

 

Torsade de pointes

Begin initial management

❑ Assess and support ABC's as needed
❑ Give oxygen
❑ Monitor ECG, blood pressure, oxymetry
❑ Establish IV access
❑ Identify and treat reversible causes

Determine if the patient has any unstable sign or symptom

Chest pain
Congestive heart failure
Hypotension
Loss of consciousness
Seizures


Perform immediate synchronized cardioversion

❑ Perform immediate synchronized cardioversion
❑ Give IV sedation if the patient is conscious
❑ Consider expert consultation

VT or uncertain rhythm

❑ Give amiodarone 150 mg IV over 10 min
❑ Repeat amiodarone as needed for a maximal dose of 2.2g/24h
❑ Prepare for elective synchronized cardioversion

SVT with aberrancy

❑ Attempt vagal maneuvers
❑ Give adenosine 6 mg rapid IV push
❑ If no conversion give 12 mg IV push
❑ May repeat 12 mg dose once

Afib with aberrancy

❑ Consider expert consultation
❑ Control rate e.g diltiazem or beta blockers

Pre-excited Afib (Afib + WPW)

❑ Consider expert consultation
❑ Avoid AV nodal blocking agents e.g adenosine, digoxin, diltiazem and verapamil
❑ Consider amiodarone 150 mg IV over 10 min

Recurrent polymorphic VT

❑ Consider expert consultation

Torsade de pointes

❑ Load with magnesium 1-2 g over 5-60 min, then infusion

Differentiating SVT from VT

Shown below is a table summarizing some clues that help differentiate SVT from VT.[1]

Clues Type of arrhythmia
Irregularly irregular rhythm Atrial fibrillation or atrial flutter with aberrancy
Previous myocardial infarction or structural heart disease Ventricular tachycardia
Ventricular rate faster than atrial rate Ventricular tachycardia
Typical RBBB or LBBB Supraventricular tachycardia
Precordial leads:
❑ Concordant
❑ No R/S pattern
❑ Onset of R to nadir longer than 100ms
Ventricular tachycardia
RBBB pattern:
❑ qR, Rs or Rr' in V1
❑ Frontal plane axis range from +90 degrees to -90 degrees
Ventricular tachycardia
LBBB pattern:
❑ R in V1 longer than 30 ms
❑ R to nadir of S in V1 greater than 60 ms
❑ qR or qS in V6
Ventricular tachycardia

For more details about differentiating VT from SVT, click here

Antiarrhythmics

Shown below is a table summarizing the choices of the antiarrhythmic drugs for the different types of tachycardia according to the 2003 ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias.[1]

BBB: Bundle branch block; LV: Left ventricle; SVT: Supraventricular tachycardia

Management of wide complex tachycardia
Ventricular tachycardia or wide QRS tachycardia of unknown origin
Procainamide (Class I, level of evidence B)
OR
Sotalol (Class I, level of evidence B)
OR
Amiodarone
OR
Cardioversion (Class I, level of evidence B)
OR
Lidocaine (Class IIb, level of evidence B)
OR
Adenosine (Class IIb, level of evidence C)
OR
Beta blocker (Class III, level of evidence C)
OR
Verapamil (Class III, level of evidence B)
Wide QRS tachycardia of unknown origin + poor LV function
Amiodarone (Class I, level of evidence B)
OR
Cardioversion (Class I, level of evidence B)
SVT + BBB
Vagal maneuvers (Class I, level of evidence B)
OR
Adenosine (Class I, level of evidence A)
OR
Verapamil (Class I, level of evidence A)
OR
Diltiazem (Class I, level of evidence A)
OR
Beta blocker (Class IIb, level of evidence C)
OR
Amiodarone (Class IIb, level of evidence C)
OR
Digoxin (Class IIb, level of evidence C)
SVT or atrial fibrillation + Preexcitation
Flecainide (Class I, level of evidence B)
OR
Ibutilide (Class I, level of evidence B)
OR
Procainamide (Class I, level of evidence B)
OR
Cardioversion (Class I, level of evidence C)

Do's

Dont's

  • Don't rely on the hemodynamic status of the patient and the heart rate to differenciate SVT from VT.

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ; et al. (2003). "ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society". J Am Coll Cardiol. 42 (8): 1493–531. PMID 14563598.
  2. 2.0 2.1 2.2 "Part 7.3: Management of Symptomatic Bradycardia and Tachycardia". Retrieved 2 March 2014.

Template:WH Template:WS